Versatile and enhanced tumour modelling in mice via somatic cell transduction
Authors:
Open Access
- 4 December 2013
- journal article
- research article
- Published by Wiley in The Journal of Pathology
- Vol. 232 (4) , 449-457
Abstract
Genetically engineered mouse (GEM) models of cancer currently comprise the most accurate way to experimentally recapitulate the human disease in the laboratory. Given recent advances in genomics and genetic screens, however, as well as an increasing urgency for the translation of effective preclinical treatments into the clinic, there is a pressing need to make these models easier and more efficient to work with. Accordingly, we have developed a versatile lentivirus‐based approach to induce tumours from somatic cells of GEMs, add or subtract gene expression and render the tumours imageable from a simple breeding stock. The vectors deliver a tamoxifen‐inducible and self‐inactivating Cre recombinase, conditional bioluminescent and fluorescent proteins and an shRNA component. Following the transduction of somatic cells, tumours are initiated by Cre‐mediated recombination of the inherited floxed alleles. Self‐inactivation of Cre expression switches on the expression of luciferase, thereby rendering the recombined cells and resulting tumours bioluminescent. We demonstrate proof of concept of this approach by inducing bioluminescent lung tumours in conditional Kras and p53 mice. We also show that a variant vector expressing shRNA alters tumour growth dynamics and the histological grade associated with the inherited genotype. This approach comprises a versatile means to induce imageable and spontaneous tumour burden in mice. The vectors can be readily customized at the bench to modify reporter readout or tumour phenotype without additional transgenic strain development or breeding. They should also be useful for inducing imageable tumours in organs other than the lung, provided that the inherited conditional genotype is sufficiently penetrant. © 2013 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland.Keywords
This publication has 34 references indexed in Scilit:
- Moderate and high amounts of tamoxifen in α-MHC-MerCreMer mice induce a DNA damage response, leading to heart failure and deathDisease Models & Mechanisms, 2013
- Rapid validation of cancer genes in chimeras derived from established genetically engineered mouse modelsBioEssays, 2011
- A Rapid and Scalable System for Studying Gene Function in Mice Using Conditional RNA InterferenceCell, 2011
- Functional Identification of Optimized RNAi Triggers Using a Massively Parallel Sensor AssayMolecular Cell, 2011
- Phosphorylation Regulates c-Myc's Oncogenic Activity in the Mammary GlandCancer Research, 2011
- Selective activation of p53-mediated tumour suppression in high-grade tumoursNature, 2010
- Imaging Primary Lung Cancers in Mice to Study Radiation BiologyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinaseNature Protocols, 2009
- Probing tumor phenotypes using stable and regulated synthetic microRNA precursorsNature Genetics, 2005
- Optimized self-excising Cre-expression cassette for mammalian cellsBiochemical and Biophysical Research Communications, 2004